Birth Control Pills and Thrombotic Risks: Differences of Contraception Methods with and without Estrogen.

Abstract:

:In Germany one-third of the women in fertile age use combined oral contraceptives (COCs), which consist mostly of ethinylestradiol (EE) and a synthetic progestin. Older COCs with norethisterone or levonorgestrel have a lower risk for venous thromboembolism (VTE) than newer COCs with desogestrel, drospirenone, or gestodene. This is also true for nonoral combined hormonal contraceptives. The risk of newer COCs containing estradiol instead of EE is not clear due to missing data. Progestin-only hormonal contraception is not associated with a significant increase of the risk for VTE with the exception of depot medroxyprogesterone acetate. Emergency contraceptions, which do not contain EE, but only levonorgestrel or ulipristal acetate, do not result in a higher risk for VTE. Oral desogestrel- or levonorgestrel-only contraceptives, intrauterine device, and etonogestrel implants are the contraception of choice in women with a history of VTE and/or suffering from thrombophilia. These safe contraceptives should be offered to women with high risk of VTE due to the much higher VTE risk in pregnancy and postpartum. The screening for thrombophilia is not indicated in every woman with the wish for contraception. This should be restricted to certain cases, for example to women with a positive history for VTE or with close relatives suffering from VTE in younger than 50 years. :Etwa 20 Millionen Frauen befinden sich aktuell im reproduktiven Alter. Ein Drittel von ihnen wendet kombinierte hormonelle Kontrazeptiva an (COC), welche meist aus Ethinylestradiol und einem synthetischen Gestagen bestehen. Das Grundrisiko für venöse Thromboembolien (VTE) für Frauen im reproduktiven Alter ist gering, steigt aber deutlich an durch Anwendung von COC oder auch in der Schwangerschaft/Wochenbett. Dies gilt auch für nichtorale COC. Hierdurch haben junge Frauen ein merklich höheres VTE Risiko als Männer bis zum Alter von 35 Jahren, danach gleicht sich das VTE-Risiko zwischen den Geschlechtern an.Die Erhöhung des VTE Risikos hängt vom verwendeten COC ab. Ältere COC mit Norethisteron oder Levonorgestrel als Gestagen haben ein niedrigeres VTE-Risiko als neuere COC. In vielen internationalen Leitlinien gelten daher mittlerweile die älteren COC als erste Wahl. Neuere COC sollten daher nur noch verordnet werden, wenn besondere Gründe hierfür vorliegen. Das VTE-Risiko von COC mit Estradiol bzw. Estradiolvalerat statt EE ist noch ungeklärt. Die Anwendung von rein gestagenhaltiger Kontrazeption erhöht das VTE-Risiko nicht signifikant mit Ausnahme von Depot-Medroxyprogesteronacetat (DMPA). Die Notfallkontrazeption („Pille danach“), welche keine Östrogene, sondern nur Levonorgestrel bzw. Ulipristalacetat enthalten, erhöhen das VTE-Risiko nicht.Orale reine Gestagenkontrazeptiva (mit Desogestrel oder Levonorgestrel), Intrauterine Kontrazeption und Etonogestrel Implantate sind die Verhütungsmittel der Wahl bei Frauen mit erhöhtem VTE-Risiko.Ein Thrombophilie-Screening ist nicht bei jeder Frau mit Kontrazeptionswunsch indiziert. Diese Testung sollte auf Frauen mit positiver VTE Eigenanamnese oder auf Frauen mit VTE-Fällen in der nächsten Verwandtschaft im Alter von unter 50 Jahren limitiert werden.

journal_name

Hamostaseologie

journal_title

Hamostaseologie

authors

Rott H

doi

10.1055/s-0039-1677806

subject

Has Abstract

pub_date

2019-02-01 00:00:00

pages

42-48

issue

1

eissn

0720-9355

issn

2567-5761

journal_volume

39

pub_type

杂志文章,评审
  • The vulnerable myocardium. Diabetic cardiomyopathy.

    abstract::Cardiovascular disease is the major cause of morbidity and mortality in subjects suffering from diabetes mellitus. While coronary artery disease is the leading cause of cardiac complications in diabetics, it is widely recognized that diabetes increases the risk for the development of heart failure independently of cor...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-09-0038

    authors: Bugger H,Bode C

    更新日期:2015-01-01 00:00:00

  • Mouse models to study von Willebrand factor structure-function relationships in vivo.

    abstract::Von Willebrand factor (VWF) structure-function relationship has been studied only through in vitro approaches. The VWF-deficient mouse model has been extremely useful to examine the in vivo function of VWF but does not allow a more subtle analysis of the relative importance of its different domains. However, consideri...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Denis CV,Marx I,Badirou I,Pendu R,Christophe O

    更新日期:2009-01-01 00:00:00

  • Potential of Multidimensional, Large-scale Biodatabases to Elucidate Coagulation and Platelet Pathways as an Approach towards Precision Medicine in Thrombotic Disease.

    abstract::Cardiovascular and especially thrombotic diseases remain a major cause of morbidity and mortality worldwide. In past years, significant improvements in understanding disease processes, risk assessment, and prediction of clinical outcome in the field of thrombosis and haemostasis have been made by using large-scale bio...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0038-1677520

    authors: Panova-Noeva M,Eggebrecht L,Prochaska JH,Wild PS

    更新日期:2019-06-01 00:00:00

  • Oxidation-specific epitopes are major targets of innate immunity in atherothrombosis.

    abstract:UNLABELLED:Atherosclerosis is a chronic inflammatory disease of the vascular wall that results from disturbed lipoprotein metabolism and increased oxidative stress. A major consequence of this is lipid peroxidation, which generates a number of breakdown products of membrane lipids that form so called oxidation-specific...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-11-0069

    authors: Bartolini Gritti B,Binder CJ

    更新日期:2016-05-10 00:00:00

  • [Protein Z deficiency in unexplained affinity to thromboses, bleedings or abortions].

    abstract:UNLABELLED:A protein Z deficiency is presumably related with a threefold risk of venous and arterial thrombosis. Mucosal bleedings and post-operative haematomas can occur more frequently. This is seen in an increased in vivo bleeding time without other plasmatic coagulation disorders or thrombopathies. Pregnancy compli...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Kiesewetter H,Radtke H,Jainz A,Schmidt FP

    更新日期:2012-01-01 00:00:00

  • [Documentation of haemophilia treatment supported by the German Hemophilia Registry].

    abstract::The DHR (Deutsches Hämophilieregister, German Haemophilia Register) records patient data on haemophilia A, haemophilia B, von Willebrand disease, and other coagulation factor deficiency disorders. The DHR has been online since 2009. The participation in the DHR leads to additional administrative workload for the hospi...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Haschberger B,Hesse J,Heiden M,Seitz R,Schramm W

    更新日期:2010-11-01 00:00:00

  • [Recurrent miscarriage or failed in-vitro fertilization: antibodies against annexin V, cardiolipin, beta-2-glycoprotein-1 and APC-resistance].

    abstract:UNLABELLED:Antibodies against annexin-V, a potent anticoagulant abundant in placental tissues, were recently controversially reported to be associated with recurrent miscarriages or failures of in-vitro-fertilization (IVF) attempts. PATIENTS, MATERIAL, METHODS:We screened 56 women (34.7 +/- 4.3 years of age: mean +/- ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Halbmayer WM,Feichtinger W,Kindermann C,Prendinger B,Böhm M

    更新日期:2005-11-01 00:00:00

  • Use of recombinant factor VIIa in the perioperative period.

    abstract::Recombinant activated factor VII (rFVIIa) is a pro-haemostatic agent that can be used for patients with haemophilia and inhibiting antibodies towards a coagulation factor. Recombinant factor VIIa is, however, increasingly used for several other indications, including patients who experience serious and life-threatenin...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Levi M

    更新日期:2009-01-01 00:00:00

  • [Fibrin monomer and factor XIII: a new concept for unexplained intraoperative coagulopathy].

    abstract::Unexplained intraoperative coagulopathies continue to be a diagnostic and therapeutic dilemma. The pathophysiology behind unexplained intraoperative coagulopathies is of great variety and complexity (preexisting coagulopathies, dilutional coagulopathy, interactions of medications etc.). We have shown in prospective st...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Korte W

    更新日期:2006-08-01 00:00:00

  • Understanding and Preventing Placenta-Mediated Pregnancy Complications.

    abstract::Placenta-mediated pregnancy complications are clinically important conditions and include preeclampsia, placental abruption, intrauterine growth restriction, and late fetal loss. Pathophysiology is complex, and may be linked to prothrombotic disorders such as antiphospholipid syndrome, whose understanding is still evo...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1055/a-1184-8388

    authors: Skeith L,Blondon M,Ní Áinle F

    更新日期:2020-08-01 00:00:00

  • [Inhibitor development after changing FVIII/IX products in patients with haemophilia].

    abstract:UNLABELLED:The retrospective observational study surveys the relationship between development of inhibitors in the treatment of haemophilia patients and risk factors such as changing FVIII products. A total of 119 patients were included in this study, 198 changes of FVIII products were evaluated. RESULTS:During the ob...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Kocher S,Asmelash G,Makki V,Müller S,Krekeler S,Alesci S,Miesbach W

    更新日期:2012-01-01 00:00:00

  • Extracellular nucleic acids as novel alarm signals in the vascular system. Mediators of defence and disease.

    abstract::Upon vascular injury or tissue damage, the exposed intracellular material such as nucleic acids, histones and other macromolecules may come into contact with vessel wall cells and circulating blood cells and may thus, have an enduring influence on wound healing and body defence processes. This short review summarizes ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-13-01-0001

    authors: Fischer S,Preissner KT

    更新日期:2013-01-01 00:00:00

  • Phospholipid inhibitors. State of the art.

    abstract::The antiphospholipid syndrome (APS) is defined by the association of arterial and/or venous thrombosis and/or pregnancy complications with the presence of at least one among the main antiphospholipid antibodies (aPL) (i. e., Lupus anticoagulants, LA, IgG and/or IgM anticardiolipin antibodies, aCL, IgG and/or IgM antiβ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/ha-1165

    authors: Galli M

    更新日期:2011-11-01 00:00:00

  • [Does FVIII-activity increase with age in patients with haemophilia A and carriers of haemophilia A?].

    abstract:UNLABELLED:The retrospective cohort study surveys the influence of age, co-morbidity and laboratory values on FVIII-activity (FVIII:C) in patients with haemophilia A with (mild n = 48, moderate n = 10, severe n = 7 and carriers n = 23). Median observation was 19 years for patients with haemophilia A and 9,5 years for c...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Delbrück C,Haferland I,Scholz K,Asmelash G,Makki V,Müller S,Krekeler S,Alesci S,Miesbach W

    更新日期:2011-11-01 00:00:00

  • Thrombophilia and its impact on pregnancy.

    abstract:UNLABELLED:In recent years thrombophilia has gained much attention as a risk factor for pregnancy complications. Whereas there is an established correlation between antiphospholipid-antibodies and pregnancy loss, data for other risk factors of thrombosis are less well established. Data suggest associations with antithr...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Pabinger I

    更新日期:2008-01-01 00:00:00

  • Arterial thrombus formation. Novel mechanisms and targets.

    abstract::Platelet and coagulation factor-dependent thrombus formation is critical to limit posttraumatic blood loss at sites of vascular injury. However, under pathological conditions like rupture of an atherosclerotic plaque, it may also lead to vessel occlusion causing myocardial infarction or stroke. Therefore, antithrombot...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Hagedorn I,Vögtle T,Nieswandt B

    更新日期:2010-08-01 00:00:00

  • Thrombin generation and venous thromboembolism.

    abstract::Venous thromboembolism is a chronic and potential fatal disease. Determination of recurrence risk is time-consuming and costly, and sometimes not feasible: many patients carry more than one risk factor, the relevance of some factors with regard to risk of recurrence is unknown, and existence of thus far unknown risk f...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Eichinger S

    更新日期:2008-02-01 00:00:00

  • Follow-up of a 6-month Programmed Sports Therapy (PST) in patients with haemophilia.

    abstract::Studies describe benefits of exercise in Patients with haemophilia (PwH), but research on training sustainability is rare. Aim of this study was to observe the follow-up of a guided 6-month training intervention in PwH. This study included 28 PwH after a training intervention (RCT) over 6 months. N=17 continued traini...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,随机对照试验

    doi:10.5482/HAMO-17-04-0016

    authors: Runkel B,Hilberg T

    更新日期:2017-01-01 00:00:00

  • Nucleic acid aptamers and their complimentary antidotes. Entering an era of antithrombotic pharmacobiologic therapy.

    abstract::The translation of fundamental science-based constructs to the preemptive identification and optimal management of individuals with or those at risk for thrombotic disorders of the cardiovascular system has taken a step closer to being realized with the development of molecular technologies that include nucleic acid a...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Becker RC,Oney S,Becker KC,Rusconi CP,Sullenger B

    更新日期:2007-12-01 00:00:00

  • Chromogenic substrates as fundamental tool to design new thrombin inhibitors. Determination of inhibition equilibrium constants.

    abstract::The structure-activity relationship of dipetalogastin II, the strongest thrombin inhibitor isolated and cloned from the bug Dipetalogaster maximus, was examined by introducing gradual changes into the molecule by means of molecular biological methods. The effect upon its inhibition equilibrium constant was determined ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1267/hämo05030267

    authors: Lopez M,Nowak G

    更新日期:2005-08-01 00:00:00

  • The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease. An emerging field.

    abstract::Coronary heart disease and stroke, the deadliest forms of cardiovascular disease (CVD), are mainly caused by atherosclerosis, a chronic inflammatory disease of the artery wall driven by maladaptive immune responses in the vessel wall. Various risk factors for CVD influence this pathogenic process, including diabetes m...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-10-0052

    authors: Polyzos KA,Ketelhuth DF

    更新日期:2015-01-01 00:00:00

  • Platelet Signaling in Primary Haemostasis and Arterial Thrombus Formation: Part 1.

    abstract::Platelets react immediately in response to traumatic vascular injury by adhesion, activation, aggregation and subsequent haemostatic plug formation. While this reaction pattern is essential for haemostasis, platelet responses can also cause occlusive thrombi in diseased arteries, leading to myocardial infarction or st...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0038-1675144

    authors: Scharf RE

    更新日期:2018-11-01 00:00:00

  • [Factor XIII in man: a review].

    abstract::Activated by calcium and thrombin, factor XIII (FXIIIa) cross-links fibrin, thus increasing the stability of the fibrin clot. Furthermore, the hemostatic and reparative function of factor XIIIa is mediated by cross-linking other proteins like alpha(2)-plasmin-inhibitor, fibronectin, and collagen. The FXIII Val34Leu po...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Dufner GS,Marbet GA

    更新日期:2002-02-01 00:00:00

  • Diagnosis and treatment of superficial vein thrombosis.

    abstract::Superficial vein thrombosis (SVT) is a common disease, characterized by an inflammatory-thrombotic process in a superficial vein. Typical clinical findings are pain and a warm, tender, reddish cord along the vein. Until recently, no reliable epidemiological data were available. The incidence is estimated to be higher ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.5482/HAMO-13-04-0027

    authors: Bauersachs RM

    更新日期:2013-08-01 00:00:00

  • Recurrent cerebral ischaemia in a pregnant woman with patent foramen ovale II° and thrombophilia.

    abstract::This case report concerns a pregnant multipara (age: 27 years) in the 16th gestational week. She developed a sudden onset of paraesthesia in her left lower arm although injecting dalteparin 5000 IU once daily subcutaneously (s. c.) due to a heterozygous factor V Leiden mutation and a prior miscarriage in the first pre...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.5482/HAMO-14-03-0022

    authors: Hecking C,Hendelmeier M,von Bardeleben R,Gröschel K,Schinzel H

    更新日期:2014-01-01 00:00:00

  • [Update of INR-selfmonitoring].

    abstract::Nearly every second patient, who needs an oral anticoagulation with vitamin K antagonists, is feasible to perform INR-self-management after participation in a structured teaching program. Patient self-testing or measuring the INR value by relatives or nurses would increase this method of control by the aid of telemedi...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Völler H,Braun S

    更新日期:2008-10-01 00:00:00

  • Cofactor-Independent Antiphospholipid Antibodies: Implications for Pathogenesis, Diagnosis, and Treatment of Antiphospholipid Syndrome.

    abstract::The antiphospholipid syndrome (APS) has occupied haemostaseologists, rheumatologists and obstetricians since its initial description 35 years ago. Its name has been coined because of the antibodies against phospholipids which were the common property of affected patients. In particular, the pathogenesis of APS has bee...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0038-1675355

    authors: Lackner KJ,Müller-Calleja N

    更新日期:2019-06-01 00:00:00

  • [Laboratory diagnosis of the lupus anticoagulants].

    abstract::The antiphospholipid syndrome is defined as the occurrence of one or more episodes of vascular thrombosis and/or miscarriage together with antiphospholipid antibodies. Some of these antibodies can be detected via coagulation assays by prolonging phospholipids-dependent assays. These unspecific inhibitors are termed lu...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1267/hämo05010050

    authors: Quehenberger P,Wagner O

    更新日期:2005-02-01 00:00:00

  • Coagulation Signalling and Metabolic Disorders: Lessons Learned from Animal Models.

    abstract::Nutrient excess in obesity drives metabolic reprogramming in multiple tissues involving extensive interorgan and intercellular crosstalk. Experimental and clinical studies show that prolonged nutrient excess often compromises metabolic adaptation propagating proobesogenic and proinflammatory responses. Chronic inflamm...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0039-1688800

    authors: Madhusudhan T,Ruf W

    更新日期:2019-06-01 00:00:00

  • [Classification of von Willebrand disease].

    abstract::Von Willebrand disease (VWD) is known for its marked heterogeneity which was already recognized by von Willebrand in 1926. The basis of phenotypic differentiation are quantitative and qualitative or functional differences between the different types and subtypes of VWD. One of the most important tools in the classific...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1267/hamo04010027

    authors: Schneppenheim R,Budde U

    更新日期:2004-02-01 00:00:00